Morning @col69, I watched that on YouTube during the week (thanks for posting) & I was blown away by how focussed the THI is on ensuring that they were at the heart (ha-ha) of innovation in cardiovascular health.
I can see Revascor being obsolete (albeit in 300yrs) as CEO is very focussed on prevention.
Exciting times ahead for THI & Mesoblast!
Cell Therapy News/Articles, page-17770
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
0.005(0.46%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $3.726M | 3.432M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 37169 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 59077 | 19 |
View Market Depth
| Last trade - 14.24pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |